课题基金 / 基金详情

The study of immunosuppressive mechanisms induced by gastrointestinal cancer during epithelial-mesnchymal transition and clinical application of this target therapy

The study of immunosuppressive mechanisms induced by gastrointestinal cancer during epithelial-mesnchymal transition and clinical application of this target therapy
胃肠癌上皮间质转化过程中免疫抑制机制的研究及靶向治疗的临床应用
批准号:
18591484
负责人:
SAKURAI Toshiharu
金额:
$2.57万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

SAKURAI Toshiharu的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Epithelial-mesenchymal transition (EMT) is thought to be a key step toward metastases, and the molecular mechanisms have been investigated from aspects of cancer cells. However the interaction between host immunity and the tumor cells during EMT has not been clarified yet In this study, we first established human pancreatic cancer cell line Panc-1 cells with typical EMT features such as decreased adhesion and increased invasion by transduction with snail gene, which is one of the essential transcription factor governing EMT. lb analyze how the snail transfectants would affect immune responses, we then cultured human PBMCs with the snail transfectants. In the culture with snail transfectants, immunosuppressive cells such as impaired CD11c^+ cells and CD4^+FoxP3^+ cells were increased as compared with the culture with the mock transfectant We further conducted GeneChip array analysis to compare gene expression between the snail transfectant and the parental cells, and identified the specific mediators involved in the snail-induced immunosuppressive mechanisms. The mAbs specific for the molecules significantly inhibited both induction of immunosuppression and tumor invasion. These data demonstrate that snail^+ tumor cells during EMT simultaneously induce immunosuppressive microenvironment, leading to acceleration of tumor metastasis. Blockade of the EMT-related molecules would be effective in simultaneously suppressing tumor metastasis and immunosuppression, both which are still critical issues in cancer therapy. This strategy could be promising to improve anti-tumor efficacies induced by various therapies for patients with cancers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
「研究成果報告書概要(和文)」より
摘自《研究结果报告摘要(日文)》
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [Kawauchi, et. al., Nishimura et al., Dezawa et al., Yoshizawa et al., 星野 幹雄, 星野 幹雄]
通讯作者: 星野 幹雄
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Yutaka Kawakami, Hidetoshi Sumimoto, Chie Kudo, Tomonori Yaguchi]
通讯作者: Tomonori Yaguchi
Dendritic cell based personalized immunotherapy based on cancer antigen research
基于癌抗原研究的树突状细胞个性化免疫治疗
DOI: --
发表时间: 2008
期刊: Frontiers in Bioscience 1;13
影响因子: --
作者: [Kawakami Y, Fujita T, Kudo C, Sakurai T, Udagawa M, Yaguchi T, Hasegawa G, Hayashi E, Ueda Y, Iwata T, Wang Q, Okada S, Tsukamoto N, Matsuzaki Y, Sumimoto H.]
通讯作者: Sumimoto H.
Molecular link between stress response and cancer and its clinical implication
  • 批准号:
    17K09396
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2017
  • 负责人:
    SAKURAI Toshiharu
  • 依托单位:
Novel molecular target in colorectal cancer and inflammatory bowel disease
  • 批准号:
    26460979
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.08万
  • 财政年份:
    2014
  • 负责人:
    SAKURAI Toshiharu
  • 依托单位:
Translational research focusing on the regulation of proteasome by Gankyrin
  • 批准号:
    23590998
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.33万
  • 财政年份:
    2011
  • 负责人:
    SAKURAI Toshiharu
  • 依托单位:
Elucidation of the resistance mechanisms of immunotherapy by the abnormal signal transduction in melanoma and development of methods to overcome it
  • 批准号:
    21591445
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    SAKURAI Toshiharu
  • 依托单位: